95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.54%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-33.72%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.05%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.05%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-89.31%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-88.89%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-88.89%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.10%
Share count expansion well above FSM's 0.13%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.08%
Slight or no buyback while FSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-47.61%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-19.81%
Negative OCF growth while FSM is at 0.14%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
16.12%
Positive FCF growth while FSM is negative. John Neff would see a strong competitive edge in net cash generation.
163.47%
10Y revenue/share CAGR under 50% of FSM's 332.46%. Michael Burry would suspect a lasting competitive disadvantage.
-10.49%
Negative 5Y CAGR while FSM stands at 55.05%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
10.49%
3Y revenue/share CAGR under 50% of FSM's 23.24%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
171.76%
10Y OCF/share CAGR under 50% of FSM's 17717.26%. Michael Burry would worry about a persistent underperformance in cash creation.
-26.75%
Negative 5Y OCF/share CAGR while FSM is at 296.25%. Joel Greenblatt would question the firm’s operational model or cost structure.
-0.73%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-6.14%
Negative 10Y net income/share CAGR while FSM is at 1357.10%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-64.60%
Negative 5Y net income/share CAGR while FSM is 2139.82%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
132.33%
3Y net income/share CAGR 1.25-1.5x FSM's 113.45%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
222.43%
10Y equity/share CAGR in line with FSM's 206.19%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
25.26%
Below 50% of FSM's 79.35%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
8.87%
Below 50% of FSM's 72.62%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-23.77%
Negative 5Y dividend/share CAGR while FSM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
86.39%
3Y dividend/share CAGR of 86.39% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-84.01%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
5.95%
Asset growth above 1.5x FSM's 2.38%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.00%
We have a declining book value while FSM shows 1.35%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
44.33%
Debt growth far above FSM's 5.55%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-30.81%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.